RITUXIMAB THERAPY IN A PATIENT WITH LOW GRADE B-CELL LYMPHOPROLIFERATIVE DISEASE AND CONCOMITANT ACQUIRED ANGIOEDEMA

Rituximab therapy in a patient with low grade B-cell lymphoproliferative disease and concomitant acquired angioedema

Rituximab therapy in a patient with low grade B-cell lymphoproliferative disease and concomitant acquired angioedema

Blog Article

Ravdeep Kaur, Aerik Anthony Williams, Catherine Baker Swift, Jason LED Light Acrylic Plaque With Couple Necklace W Caldwell Wake Forest University School of Medicine, Wake Forest University, Winston-Salem, NC, USA Abstract: Acquired angioedema is often associated with significant morbidity.An underlying lymphatic malignancy, autoimmune disorder, adenocarcinoma, or other malignancy may be present.Screening for Speed Sensor Wire these disorders should occur in all patients with acquired angioedema as treatment may result in resolution of angioedema.

Keywords: complement, C1-INH deficiency, ecallantide, hemopathy.

Report this page